Silence Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Silence Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silence Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silence Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $40k | 7.8k | 5.19 |
| 2025-03-31 | $100k | 35k | 2.82 |
| 2024-12-31 | $26k | 3.8k | 6.88 |
| 2024-03-31 | $208k | 9.6k | 21.60 |
| 2021-12-31 | $157k | 6.7k | 23.33 |